Cephalexin Dosing for Cellulitis
For adult patients with cellulitis, the recommended dose of cephalexin is 500 mg orally four times daily (every 6 hours) for 5 days, with extension of therapy if the infection has not improved within this time period. 1, 2
Standard Adult Dosing Regimen
- The Infectious Diseases Society of America (IDSA) recommends cephalexin 500 mg four times daily as the standard oral regimen for typical non-purulent cellulitis 1
- FDA-approved dosing for skin and skin structure infections is 500 mg every 12 hours, though for more severe infections, larger doses (up to 4g daily) may be needed 3
- The usual duration of therapy is 5 days, but treatment should be extended if clinical improvement has not occurred 2, 1
- Recent research suggests high-dose cephalexin (1000 mg four times daily) may result in fewer treatment failures compared to standard dosing (500 mg four times daily), though with slightly more minor adverse effects 4
Pediatric Dosing Regimen
- For children, the recommended daily dosage is 25-50 mg/kg divided into four doses 3
- For skin and skin structure infections in pediatric patients, the total daily dose may alternatively be divided and administered every 12 hours 3
- In severe infections, the pediatric dosage may be doubled 3
Clinical Considerations
- Cephalexin is the oral agent of choice for treating cellulitis caused by methicillin-susceptible Staphylococcus aureus (MSSA) and streptococci 1
- For non-purulent cellulitis without systemic signs of infection, oral antibiotics like cephalexin are appropriate for outpatient management 1, 2
- MRSA is an unusual cause of typical cellulitis - β-lactam monotherapy with cephalexin is recommended in the absence of abscess, ulcer, or purulent drainage 1
- Adding trimethoprim-sulfamethoxazole to cephalexin does not improve outcomes in patients with non-purulent cellulitis 5
Special Situations
- Hospitalization should be considered if there is concern for deeper infection, poor adherence to therapy, immunocompromise, or if outpatient treatment is failing 2, 1
- For cellulitis associated with penetrating trauma, evidence of MRSA infection elsewhere, nasal colonization with MRSA, or injection drug use, consider adding coverage for MRSA 1
- Elevation of the affected area and treatment of predisposing factors (such as edema, tinea pedis, or venous insufficiency) are important adjunctive measures 2, 1
- For non-diabetic adult patients, systemic corticosteroids (e.g., prednisone 40 mg daily for 7 days) could be considered as they may attenuate the inflammatory response 2, 1
Common Pitfalls to Avoid
- Don't extend treatment unnecessarily - 5 days is as effective as 10 days for uncomplicated cellulitis if clinical improvement has occurred 1
- Don't overlook underlying conditions that may predispose to recurrent cellulitis (tinea pedis, venous insufficiency, lymphedema) 1
- Don't automatically add MRSA coverage for typical non-purulent cellulitis without risk factors for MRSA 1
- Don't forget to examine interdigital toe spaces in lower-extremity cellulitis, as treating fissuring or maceration may reduce recurrence 2
- Don't miss the opportunity to consider once-daily dosing alternatives in appropriate cases - some studies suggest once-daily cefadroxil may be as effective as four-times-daily cephalexin for certain odontogenic infections 6